We are a medical device company that develops, manufactures, markets and sells point-of-care cellular imaging systems. Our patented and FDA-cleared VivaScope® technology provides physicians with real-time images of the epidermis and superficial dermis of the skin, as well as other epithelial tissues at a cellular level that can be interpreted by the physician at the bedside and/or transferred securely to a pathologist on VivaNet®, our HIPAA-compliant private telepathology network for remote diagnosis. With sensitivity and specificity that can rival the current “gold standard”, clinical histopathology (illustrated below right), but without all of the associated costs of a traditional biopsy, our platform imaging technology has the potential to significantly improve patient outcomes while simultaneously reducing costs.
Company profile
Website
CEO
L. Michael Hone
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
161406957
Latest filings (excl ownership)
15-12G
Securities registration termination
31 Jul 14
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jul 14
8-K
Entry into a Material Definitive Agreement
8 Jul 14
8-K
Entry into a Material Definitive Agreement
9 Jun 14
8-K
Caliber Imaging & Diagnostics Appoints William F. O’Dell to Board of Directors
14 May 14
10-Q
2014 Q1
Quarterly report
9 May 14
10-K/A
2013 FY
Annual report (amended)
30 Apr 14
8-K
Entry into a Material Definitive Agreement
30 Apr 14
8-K
Caliber Imaging & Diagnostics Names Richard C. Christopher to Chief Financial Officer
20 Mar 14
10-K
2013 FY
Annual report
12 Mar 14